Development and Validation of a Smartphone-Based App for the Longitudinal Assessment of Anxiety in Daily Life.


Journal

Assessment
ISSN: 1552-3489
Titre abrégé: Assessment
Pays: United States
ID NLM: 9431219

Informations de publication

Date de publication:
06 2023
Historique:
pmc-release: 01 06 2024
medline: 1 5 2023
pubmed: 1 1 2022
entrez: 31 12 2021
Statut: ppublish

Résumé

Current methods to assess human anxiety often ignore that anxiety is a dynamic process and have limitations such as high recall bias and low generalizability to real life. Smartphone apps using ecological momentary assessment (EMA) may overcome such limitations. We developed a smartphone app for the longitudinal evaluation of anxiety symptoms using EMA. We assessed the feasibility (retention and compliance) and psychometric properties (reliability and validity) of the app over 6 months in a sample of 99 participants with different levels of anxiety. The EMA-based smartphone app was highly feasible. It showed excellent within-person and between-person reliability, high convergent and moderate discriminant validity, and significant incremental validity. Assessing anxiety longitudinally using a smartphone and following EMA principles is feasible and can be reliable and valid. Studies combining EMA-based anxiety longitudinal assessments with other assessment methods deserve further research and may offer novel insights into human anxiety.

Identifiants

pubmed: 34969314
doi: 10.1177/10731911211065166
pmc: PMC9301625
mid: NIHMS1822141
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

959-968

Subventions

Organisme : NIAAA NIH HHS
ID : R01 AA027264
Pays : United States

Références

J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
Psychol Med. 2014 Jul;44(9):1793-808
pubmed: 24074230
Psychol Assess. 2009 Sep;21(3):425-36
pubmed: 19719353
Psychol Rev. 1995 Apr;102(2):246-68
pubmed: 7740090
Pers Soc Psychol Bull. 2006 Jul;32(7):917-29
pubmed: 16738025
J Med Internet Res. 2017 Apr 26;19(4):e132
pubmed: 28446418
Eur J Pain. 2009 Apr;13(4):354-65
pubmed: 18603458
Psychol Assess. 2003 Dec;15(4):456-66
pubmed: 14692842
Psychol Med. 2018 Jan;48(2):208-228
pubmed: 28641609
Annu Rev Psychol. 1998;49:377-412
pubmed: 9496627
J Res Pers. 2013 Dec;47(6):
pubmed: 24198441
Depress Anxiety. 2009;26(12):1066-85
pubmed: 19957279
Depress Anxiety. 2017 Jun;34(6):518-525
pubmed: 28504859
J Abnorm Psychol. 2020 Jan;129(1):56-63
pubmed: 31868388
Nat Rev Neurosci. 2013 Jul;14(7):488-501
pubmed: 23783199
Mol Psychiatry. 2016 Sep;21(9):1180-7
pubmed: 27240533
PLoS One. 2020 Apr 20;15(4):e0231783
pubmed: 32310979
Annu Rev Clin Psychol. 2008;4:1-32
pubmed: 18509902
J Anxiety Disord. 2014 Dec;28(8):925-37
pubmed: 25445083
Assessment. 2021 Apr;28(3):796-812
pubmed: 32680433
Behav Res Ther. 1990;28(6):487-95
pubmed: 2076086
Behav Res Ther. 1995 Mar;33(3):335-43
pubmed: 7726811
J Abnorm Psychol. 2019 Oct;128(7):723-734
pubmed: 31464449
J Res Pers. 2011 Feb 1;45(1):2-9
pubmed: 21516166
J Am Acad Child Adolesc Psychiatry. 2021 Mar;60(3):377-387
pubmed: 32553785
Emot Rev. 2015 Oct;7(4):355-361
pubmed: 27617032
Curr Top Behav Neurosci. 2010;2:21-35
pubmed: 21309104
Nat Rev Dis Primers. 2017 May 04;3:17024
pubmed: 28470168
Assessment. 2022 Mar;29(2):136-151
pubmed: 32909448
Annu Rev Neurosci. 2021 Jul 8;44:129-151
pubmed: 33556250
J Med Internet Res. 2019 Dec 6;21(12):e14475
pubmed: 31808748
World Psychiatry. 2020 Feb;19(1):114-115
pubmed: 31922662

Auteurs

Lydia Fortea (L)

Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
Instituto de Salud Carlos III, Madrid, Spain.
University of Barcelona, Spain.

Miquel Tortella-Feliu (M)

University of the Balearic Islands, Mallorca, Spain.

Asier Juaneda-Seguí (A)

Instituto de Salud Carlos III, Madrid, Spain.
University of Barcelona, Spain.
Bellvitge Biomedical Research Institute, Barcelona, Spain.

Víctor De la Peña-Arteaga (V)

University of Barcelona, Spain.
Bellvitge Biomedical Research Institute, Barcelona, Spain.

Pamela Chavarría-Elizondo (P)

Instituto de Salud Carlos III, Madrid, Spain.
University of Barcelona, Spain.
Bellvitge Biomedical Research Institute, Barcelona, Spain.

Laia Prat-Torres (L)

Bellvitge Biomedical Research Institute, Barcelona, Spain.

Carles Soriano-Mas (C)

Instituto de Salud Carlos III, Madrid, Spain.
Bellvitge Biomedical Research Institute, Barcelona, Spain.
Universitat Autònoma de Barcelona, Spain.

Sean P Lane (SP)

Purdue University, West Lafayette, IN, USA.

Joaquim Radua (J)

Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
Instituto de Salud Carlos III, Madrid, Spain.
Karolinska Institutet, Stockholm, Sweden.
King's College London, UK.

Miquel A Fullana (MA)

Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
Instituto de Salud Carlos III, Madrid, Spain.
Hospital Clinic, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH